PROGRESSIVE DISEASE
Clinical trials for PROGRESSIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE DISEASE trials appear
Sign up with your email to follow new studies for PROGRESSIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets recurrent ovarian and endometrial cancers
Disease control OngoingThis early-phase study tests a combination of two oral and intravenous drugs (niraparib and copanlisib) in people whose endometrial, ovarian, peritoneal, or fallopian tube cancer has returned. The main goal is to find the safest dose and understand side effects. About 31 particip…
Matched conditions: PROGRESSIVE DISEASE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
Triple-Drug cocktail shows promise for Tough-to-Treat colorectal cancer
Disease control OngoingThis study tests a combination of two targeted drugs (encorafenib and cetuximab) plus an immunotherapy drug (nivolumab) in people with advanced colorectal cancer that has a specific BRAF gene change and has not responded to standard treatments. The goal is to see if this triple t…
Matched conditions: PROGRESSIVE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC